Showing 1 to 3 of 3 results


Australian Man Meets UK Stem Cell Donor After Life-Saving Transplant
A 31-year-old Australian man with blood cancer, Luke Melling, traveled 10,000 miles to meet Alastair Hawken, his stem-cell donor from Grantham, Lincolnshire, after a successful transplant facilitated by the NHS registry; they are encouraging others to join.
Australian Man Meets UK Stem Cell Donor After Life-Saving Transplant
A 31-year-old Australian man with blood cancer, Luke Melling, traveled 10,000 miles to meet Alastair Hawken, his stem-cell donor from Grantham, Lincolnshire, after a successful transplant facilitated by the NHS registry; they are encouraging others to join.
Progress
44% Bias Score


Record Bone Marrow Transplants in Spain Highlight Graft-versus-Host Disease Challenge
A record 3,717 bone marrow transplants were performed in Spain in 2023, with 39% being allogeneic (donor other than identical twin), increasing the risk of graft-versus-host disease (GvHD), a severe complication causing debilitating symptoms and impacting patients' quality of life, though new target...
Record Bone Marrow Transplants in Spain Highlight Graft-versus-Host Disease Challenge
A record 3,717 bone marrow transplants were performed in Spain in 2023, with 39% being allogeneic (donor other than identical twin), increasing the risk of graft-versus-host disease (GvHD), a severe complication causing debilitating symptoms and impacting patients' quality of life, though new target...
Progress
32% Bias Score

Drug Trial Offers Hope for Acute Myeloid Leukemia Remission
Michelle Gidion, a 56-year-old mother of four, was diagnosed with acute myeloid leukemia after initially ignoring leg bruises. Despite initial treatment failures, a groundbreaking drug trial using bleximenib resulted in her remission, highlighting potential advancements in leukemia treatment.

Drug Trial Offers Hope for Acute Myeloid Leukemia Remission
Michelle Gidion, a 56-year-old mother of four, was diagnosed with acute myeloid leukemia after initially ignoring leg bruises. Despite initial treatment failures, a groundbreaking drug trial using bleximenib resulted in her remission, highlighting potential advancements in leukemia treatment.
Progress
8% Bias Score
Showing 1 to 3 of 3 results